Cannabis Industry Growth Through M&A: 5 Deals Transforming The Market

The cannabis industry has witnessed a wave of consolidation in recent years. Companies in the space have been strategically merging and acquiring to expand. From Canadian producers to U.S.-based multistate operators, these merger and acquisition deals paint a picture of a sector that is evolving and positioning itself for long-term growth.

5.Organigram Acquires Motif Labs

Canadian cannabis giant Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) acquired Motif Labs in 2014 for CA$90 million ($67 million). With the move, Organigram became Canada’s largest cannabis company by market share. Since then, Organigram has continued to grow, reporting record net revenue of CA$70.8 million in the third quarter of fiscal 2025 – a 72% increase year-over-year and 7.9% sequential growth – demonstrating how past strategic acquisitions contributed to its long-term expansion.

4.SNDL Acquires Indiva Assets

In late 2014, SNDL Inc. (NASDAQ: SNDL) acquired Indiva Limited’s business and assets for approximately $22.7 million, gaining Indiva’s 40,000-square-foot London, Ontario facility and a portfolio of edibles brands, including Pearls by Grön, No Future, and Bhang Chocolate. CEO Zach George said at the time that the acquisition would strengthen SNDL’s product offerings and reinforce its leadership in Canada’s cannabis sector. Over the years, this strategic move contributed to the company’s growth, culminating in net revenue of CA$244.8 million ($175.3 million) in the second quarter of 2025 — a 7.3% increase year-over-year — while gross profit rose 16.2% to CA$67.6 million, reflecting the lasting impact of its early acquisitions.

3.Cansortium Merges with RIV Capital

Florida-based Cansortium merged with RIV Capital in an all-stock deal in December 2024. The deal was valued at roughly $21.6 million. With the merger, Cansortium added New York retail, wholesale and cultivation operations to its multi-state footprint. Cansortium changed its corporate name to FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) effective Feb. 5, 2025. Fluent’s second quarter results were below expectations with $26.7 million in revenue for the period compared to $27.3 million in the corresponding quarter of last year. A newly appointed Interim CEO, Dave Vautrin, is expected to lead a strategic and operational pivot.

2.Curaleaf Acquires Northern Green Canada

Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) acquired Northern Green Canada (NGC), a vertically integrated Canadian cannabis producer with EU-GMP certification, in April 2024. The deal strengthened Curaleaf’s presence in key European markets, including Germany, Poland, and the U.K. It also allowed the company entry into emerging markets, including Australia and New Zealand. The deal was valued at roughly $16 million and was paid in Curaleaf’s subordinate voting shares, subject to typical post-closing adjustments. Net revenue amounted to $314.5 million, representing a year-over-year decrease of 8% compared to the second quarter 2024 revenue of $342.3 million. Gross profit totaled $152.6 million and gross margin of 49%, an increase of 160 basis points year-over-year.

1.Tilray Acquires Four Craft Breweries From Molson Coors

Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY) acquired four craft breweries from Molson Coors in a deal valued at $23 million in mid-2024. The acquisition, finalized in September 2024, included Hop Valley Brewing Company, Terrapin Beer Co., Revolver Brewing, and Atwater Brewery. This move expanded Tilray’s U.S. craft beer portfolio to 18 brands. This acquisition aligns with Tilray’s strategy to diversify its portfolio beyond cannabis products, positioning the company as a significant player in the U.S. craft beer market. The company’s fiscal 2025 net revenue totaled $821 million, while international cannabis revenue grew by 19%, with the fourth quarter increasing by 71% and when excluding Australia, European cannabis revenue grew 112%.